Fwd: HCV Advocate Email Alert

[Guest guest]

> Date: Thu, 22 Jan 2009 20:40:32 -0500

> Subject: HCV Advocate Email Alert

>

> To:

> CC:

>

>

>

> Hello,

>

> The following items have been posted to www.hcvadvocate.org and

www.hbvadvocate.org

>

>

>

> *** Hepatitis C Streaming Videos:

> The excellent videos below have been produced by the Massachusetts Department

of Public Health Viral Hepatitis Program and are available in English, Spanish,

and Portuguese.

> Living with Hepatitis C: English - A film about hepatitis C from the

Massachusetts Department of Public Health (Windows Media File)

>

> Living with Hepatitis C: Portuguese (Windows Media File)

>

> Vivir con Hepatitis C: Aprenda Más - Asegúrese (Living with Hepatitis C) -

Una película sobre la hepatitis C, por el Departamento de Salud Pública de

Massachussetts (Windows Media File)

>

>

> ***ACTION ALERT: Sign On Letter - Viral Hepatitis in Senate Economic Stimulus

Bill

>

>

>

> *** Updated and Redesigned - Next Steps: When Treatment Isn't Working, by

Lucinda Porter, RN

>

>

>

> *** Updated: HCSP Hepatitis C Facts Series - HCV Education and Support

>

> Be sure to check out all of the updated factsheets in this series HCV

Education and Support

> * How to Tell Children They Have Hepatitis

>

> * Finding a Hepatitis C Support Group

>

> * A Brief History of HCV

>

> * Hepatitis C: Disclosure

>

> * Dispelling Myths about HCV

>

> * Testing Positive for Antibodies to the Hepatitis C Virus

>

>

>

> Thanks!

>

> Alan Franciscus

> Executive Director, Hepatitis C Support Project

> Editor-in-Chief, HCV Advocate

>

>

>

> **Questions and Comments: If you have questions or comments please do not

reply to this email. Questions and/or comments can be directed to

alanfranciscus@...

>

> **Unsubscribe Information:

[Guest guest]

>

> To:

> Subject: HCV Advocate Email Alert

> Date: Sat, 7 Mar 2009 15:32:34 -0500

>

>

> Hello,

>

> The following items have been posted to www.hcvadvocate.org and

www.hbvadvocate.org

>

>

>

> *** HCV Advocate Newsletter: March, 2009

>

>

> In This Issue:

>

> Retrovirus Conference Report on HIV/HCV Coinfection

> Liz Highleyman

>

> HCV SnapShots

> Alan Franciscus, Editor-in-Chief

>

> HealthWise: HCV Treatment and Sexual Dysfunction

> Lucinda Porter, RN

>

> HCV Treatment after Liver Transplantation

> Alan Franciscus, Editor-in-Chief

>

> Medical Writers' Circle Re-Launch

>

>

>

> *** HCV Drug Pipeline: Updated March 3, 2009

>

> Check out the latest in Hepatitis C Treatment and Drug Development

>

>

> *** HBV Journal Review, March 2009, by Kukka

>

>

> *** Hepatitis Journal Review , February 2009, by Liz Highleyman

>

> In This Issue:

>

> Extended Treatment for Genotype 1b

>

> Hepatocellular Carcinoma Risk

>

> Biliary and Pancreatic Cancer

>

> HCV Diagnosis in Coinfected People

>

> Pegasys vs. PegIntron for Coinfected Patients

>

>

>

> *** Updated HBV Advocate Easy B Factsheets

>

>

>

> *** Social Security Continuing Disability Reviews, by Jacques Chambers, CLU

>

>

>

>

>

> *** HCV ADVOCATE WEEKLY NEWS REVIEW:

> A Review of HCV, HBV and HIV/HCV Coinfection Related News and Highlights

>

> Week Ending: March 7, 2009

>

> Alan Franciscus

> Editor-in-Chief

>

> To download pdf version click here

>

>

> This Issue:

>

>

>

> How Inflammatory Disease Causes Fatigue

> Economic Recovery Payments Coming For People Who Receive Social Security And

SSI Benefits

> High hepatitis C viral load increases risk of death in HIV/HCV coinfected

patients

> FTC Clears ZymoGenetics-Bristol-Myers Deal For Hepatitis C Drug Development

> Study Showing Improved Virologic Response with Nitazoxanide in Chronic

Hepatitis C Published in Gastroenterology

> Q & A: could I catch hepatitis C?

> Vertex Pharmaceuticals Strengthens HCV Drug Development Portfolio, Adds Novel

Polymerase Inhibitors to Shape New Combinations with Telaprevir

> Combination therapy eases fibromyalgia symptoms

> Hep C highest on North Coast

> Call for EU action on hepatitis death toll

> RF Ablation Linked to Improved Liver Cancer Survival

> Rates of Liver Cancer are Rising, but Survival is Increasing

> Continuous antiretroviral therapy improves survival in HIV/hepatitis C

co-infected patients with liver cirrhosis

> Proteomics Prove Accurate In Identifying Liver Cancer

> Sick, seeking answers

> NYC dialysis center tied to 9 hepatitis C cases

> Results may determine fate of Human Genome Sciences

> Electrochemical solution to virus detection

> HBV Polymerase Resistance Mutations May Be Antagonistic

>

>

>

> Thanks!

>

> Alan Franciscus

> Executive Director, Hepatitis C Support Project

> Editor-in-Chief, HCV Advocate

>

>

>

> **Questions and Comments: If you have questions or comments please do not

reply to this email. Questions and/or comments can be directed to

alanfranciscus@...

>

> **Unsubscribe Information:

[Guest guest]

>

> To:

> Subject: HCV Advocate Email Alert

> Date: Thu, 19 Mar 2009 15:43:07 -0400

>

>

> Hello,

>

> The following items have been posted to www.hcvadvocate.org and

> www.hbvadvocate.org

>

>

>

> *** HCV Drug Pipeline: Updated March 13, 2009

>

> Check out the latest in Hepatitis C Treatment and Drug Development

>

>

> *** Medical Writers' Circle: HBV in Chidren, by Philip Rosenthal, MD

>

> *** Help with COBRA Premiums, by Jacques Chambers, CLU

>

> *** Top Ten Downloads - March 19, 2009

>

>

>

> *** HCV ADVOCATE WEEKLY NEWS REVIEW:

> A Review of HCV, HBV and HIV/HCV Coinfection Related News and Highlights

>

> Week Ending: March 14, 2009

>

> Alan Franciscus

> Editor-in-Chief

>

> To download pdf version click here

>

>

> This Issue:

>

>

> Artificial Liver Extends Lives

> Two transplants later, couple longs for home

> Merck to buy Schering-Plough for US$41.1-billion

> Human Genome hepatitis C drug disappoints, shares crash

> Infection control flaws found at most Nev. Clinics

> Scripps Research Team Identifies Key Molecules that Inhibit Viral

> Production

> 16 patients have hepatitis in Army needle scare

> IHC cleared after carer catches hepatitis

> Public health warning issued over Mississauga tattoo parlour

> Ethnic Differences Found for Fatty Liver Disease and Insulin Resistance

> Hepatitis C increased risk for immune thrombocytopenic purpura

> FDA Approves Expanded Indication for Peginterferon-Based Combination

> Therapy for Chronic HCV

> VA Denies Hepatitis Results

> Roche and Genentech Reach a Friendly Agreement to Combine the Two

> Organizations and Create a Leader in Healthcare Innovation

> Vertex Pharmaceuticals Closes on Acquisition of ViroChem Pharma

> Anadys CEO says in late-stage partnership discussions

> Doctor fears needle disease outbreak

>

>

>

>

> Thanks!

>

> Alan Franciscus

> Executive Director, Hepatitis C Support Project

> Editor-in-Chief, HCV Advocate

>

>

>

> **Questions and Comments: If you have questions or comments please do not

> reply to this email. Questions and/or comments can be directed to

> alanfranciscus@...

>

> **Unsubscribe Information:

[Guest guest]

>

> To:

> Subject: HCV Advocate Email Alert

> Date: Wed, 22 Apr 2009 14:36:27 -0400

>

>

>

> Hello,

>

> The following items have been posted to www.hcvadvocate.org and

> www.hbvadvocate.org.

>

>

>

> *** Action Alert

>

> SENATE ACTION ALERT: Increase Funding to the Division of Viral Hepatitis to

> a Total of $50 Million

>

> *** Media Release: LARGE SCALE AUSTRALIAN HEPATITIS C STUDY SHOWS NEED TO

> TREAT SOONER

>

>

>

> *** HCV Drug Pipeline: Updated April 21, 2009

>

> Check out the latest in Hepatitis C Treatment and Drug Development

>

>

>

> *** Medical Writers' Circle: Overview of Treatment of Hepatitis B, by

> Frenette, MD and Gish, MD

>

>

>

> *** MORE New HBV Factsheet Series

>

> Hepatitis B Basics: Hepatitis B Antigen and Antibody Tests

>

> HBV Fact Series: HBV Benefits and Disability Issues: Getting Disability

> Benefits Under Social Security, by Jacques Chambers, CLU

>

>

>

> *** HCV ADVOCATE WEEKLY NEWS REVIEW:

> A Review of HCV, HBV and HIV/HCV Coinfection Related News and Highlights

>

> Week Ending: April 18, 2009

>

> Alan Franciscus

> Editor-in-Chief

>

> To download pdf version click here

>

>

> This Issue:

>

>

> Editorial: Addiction Behind Bars

> Newark program trades clean needles with 600 addicts

> Vaccination fears over plan for Hepatitis B jabs for babies

> Legislation drafted for bloodwork uniformity: Hepatitis B link prompts

> action

> Cancelled jailhouse tattoo program lauded

> Liver donor comes through for ailing field lieutenant

> Can-Fite set for liver cancer treatment study

> Patients at Dakota Dunes, SD clinic tested for possible infection

> Do patients at risk for B-cell malignancy need antiviral treatment?

> Report: Stroke's effects hurt Desai in defense effort

> Formula for justice Chemist snags $45M settlement after blowing whistle on

> med company

> Miami VA tests find 7 cases of hepatitis C, 1 HIV

>

> Thanks!

>

> Alan Franciscus

> Executive Director, Hepatitis C Support Project

> Editor-in-Chief, HCV Advocate

>

>

>

> **Questions and Comments: If you have questions or comments please do not

> reply to this email. Questions and/or comments can be directed to

> alanfranciscus@...

>

> **Unsubscribe Information:

[Guest guest]

>

> To:

> Subject: HCV Advocate Email Alert

> Date: Mon, 1 Jun 2009 13:21:50 -0400

>

>

>

> Hello,

>

> The following items have been posted to www.hcvadvocate.org and

> www.hbvadvocate.org.

>

>

>

> *** HCV Advocate Newsletter: June, 2009

>

> To download pdf version click here

>

> In This Issue:

>

> EASL 2009

> Alan Franciscus, Editor-in-Chief

>

> HealthWise: What the Heck is Hepatotoxicity?

> Lucinda Porter, RN

>

> HIV/HCV Coinfection News from EASL

> Liz Highleyman

>

> Disability & Benefits: An Overview of Disability Insurance Coverage

> Jacques Chambers, CLU

>

>

>

> ***HBV Journal Review: June 2009, by Kukka

>

>

>

> ***Hepatitis Journal Review: May, 2009, by Liz Highleyman

> In This Issue:

>

> Ribavirin Prevents Relapse

>

> Telaprevir

>

> Sorafenib for Cirrhosis

>

> CD4 Recovery in Coinfected Patients

>

> Injection Drug Use

>

>

>

> *** Top 10 Hepatitis B Downloads of the Month Updated May 20, 2009

>

>

>

> *** Top 10 Hepatitis C Downloads of the Month Updated May 20, 2009

>

>

>

> *** Updated Schedule of HCSP Hepatitis C Training Workshops for 2009

> Take a look to find out if our very popular training workshops are coming

> to where you live

>

>

>

> *** HCV ADVOCATE WEEKLY NEWS REVIEW:

> A Review of HCV, HBV and HIV/HCV Coinfection Related News and Highlights

>

> Week Ending: May 30, 2009

>

> Alan Franciscus

> Editor-in-Chief

>

> To download pdf version click here

>

>

> This Issue:

>

> Statins May Potentiate Inhibition of Hepatitis C Virus Replication

> A Potential Drug For Liver Carcinoma

> Correctional Facilities and Viral Hepatitis

> Government Responds To Archer Inquiry

> Antibody to hepatitis B core antigen as a screening test for occult

> hepatitis B virus infection in Egyptian chronic hepatitis C patients

> Look Back - Hepatitis B Awareness Month

> FDA Working Group Recommends Revising Acetaminophen Dosing, Labels

> New Device For Liver Cancer Cleared

> New treatment option for patients with chronic hepatitis C

> Some donor factors affect outcomes for HCV-positive liver transplant

> recipients

> Severe hepatitis patients to receive special state support

> Illinois Senate Supports Medical Marijuana Bill

> Environmental Pollution Increases Risk Of Liver Disease, Study Finds

>

> Thanks!

>

> Alan Franciscus

> Executive Director, Hepatitis C Support Project

> Editor-in-Chief, HCV Advocate

>

>

>

> **Questions and Comments: If you have questions or comments please do not

> reply to this email. Questions and/or comments can be directed to

> alanfranciscus@...

>

> **Unsubscribe Information:

[Guest guest]

>

> To:

> Subject: HCV Advocate Email Alert

> Date: Wed, 1 Jul 2009 14:21:59 -0400

>

>

>

> Hello,

>

> The following items have been posted to www.hcvadvocate.org and

www.hbvadvocate.org.

>

>

>

> ***HCV Advocate on Twitter

>

> Join the HCV Advocate on Twitter (www.twitter.com/hcvadvocate) to find out the

lastest updates posted to the HCV Advocate Web site, our traveling training

program and the latest in our advocacy efforts.

>

>

> ***July 2009 HCV Advocate

> Download English printable version

> --------

>

> In This Issue:

>

> Pregnancy Drug Categories

> Alan Franciscus, Editor-in-Chief

>

> HealthWise: Hepatitis C and Metabolic Syndrome

> Lucinda Porter, RN

> FDA Takes Action on Acetaminophen

> Liz Highleyman

> Book Review - Healing Hepatitis

> Lucinda Porter, RN

> Consequences of Hepatitis C - Cost of a Baby boomer Epidemic of Liver Disease

> Alan Franciscus, Editor-in-Chief

>

>

> *** HBV Journal Review, July 2009, by Kukka

>

> ***HEPATITIS JOURNAL REVIEW:

> A Bi-Monthly Publication of the Hepatitis Support Project

>

> June 29 , 2009

> Volume 6, Issue 6

> Liz HighleymanTo download pdf version click here

>

> In This Issue:

>

> Retreatment of Nonresponders

>

> Racial Differences in Interferon Response

> Interferon-Signaling Genes

>

> Persistent HCV after SVR

>

> HCV Sexual Transmission

>

>

> ***SSA Survivors' Benefits, by Jacques Chambers, CLU, Benefits Consultant

> To download pdf version click here

> In addition to providing benefits to immediate relatives of workers insured

under Social Security while the worker is still alive, Social Security provides

benefits to a surviving spouse, ex-spouse, child, or parent of an insured

worker. This article describes survivors' benefits. Read more......

>

> *** Top 10 HCV Downloads of the Month (June 09)

> Las 10 descargas más frecuentes del mes

>

> *** Top 10 HBV Downloads of the Month (June 09)

>

>

>

> *** Updated Schedule of HCSP Hepatitis C Training Workshops for 2009

> Click Here

>

> Take a look to find out if our very popular training workshops are coming to

where you live

>

>

>

> *** HCV ADVOCATE WEEKLY NEWS REVIEW:

> A Review of HCV, HBV and HIV/HCV Coinfection Related News and Highlights

>

> Week Ending: June 27, 2009

>

> Alan Franciscus

> Editor-in-Chief

>

> To download pdf version click here

>

>

> This Issue:

>

> Hepatitis C Virus Infection and the Risk of Coronary Disease

> What I need to know about Liver Transplantation

> Women with Hypothyroidism at Increased Risk of Liver Cancer

> Providers Often Fail to Inform Patients of Abnormal Test Result

> Health of young offenders is poor

> CDC Researchers Release Latest Hepatitis A, B, and C Statistics

> HBeAg-Positive Pregnant Women With HBV DNA Warrant Further Assessment to

Prevent Transmission to Infant: Presented at ICC

> Did Steve Jobs' money buy him a faster liver transplant?

> U.S. pursues crackdown on healthcare fraud

> Groups urge FDA to release info on rejected drugs

> Should you get tested for hepatitis C?

> Hepatitis C Cases on the Rise in Langlade County

> Insulin Resistance Among Chronic Hepatitis C

> Conatus Pharmaceuticals Initiates A Second Phase 2 Clinical Trial For The

Treatment Of Hepatitis

> OraSure says FDA seeks more study on hepatitis C test

> Hepatitis C warning for cocaine snorters

> Liver Lines

> Teenager Jazzy de Lisser's award-winning film about living with killer disease

hepatitis C

> Fury as heroin addicts get " one hit kits " from Boots

> Three-Year Data Support Peginterferon Alfa-2a for HBeAg-Negative Chronic

Hepatitis B

> HIV Coinfection Has Little Effect on Response to Chronic Hepatitis B Treatment

>

> Thanks!

>

> Alan Franciscus

> Executive Director, Hepatitis C Support Project

> Editor-in-Chief, HCV Advocate

>

>

>

> **Questions and Comments: If you have questions or comments please do not

reply to this email. Questions and/or comments can be directed to

alanfranciscus@...

>

> **Unsubscribe Information:

[Guest guest]

There is a good piece about lifestyle considerations if a patient chooses not to

do treatment.

>

> To:

> Subject: HCV Advocate Email Alert

> Date: Tue, 1 Sep 2009 18:16:33 -0400

>

>

>

> Hello,

>

> The following items have been posted to www.hcvadvocate.org and

> www.hbvadvocate.org.

>

>

>

> ***Action Alert:

> Help the National Viral Hepatitis Roundtable fill the room with

> congressional staffers. Click here

>

>

> *** HCV Advocate Newsletter: September 2009

> Download English printable version--------

>

>

> In This Issue:

>

> Vibrio Vulnificus

> Alan Franciscus, Editor-in-Chief

>

> HealthWise: Choosing Not to Treat Hepatitis C

> Lucinda Porter, RN

>

> HCV & Native Americans

> Alan Franciscus, Editor-in-Chief

>

> HIV/HCV Coinfection Updates from the International AIDS Society Conference

>

> Liz Highleyman

>

> Blueberries, Asparagus and HCV

> C.D. Mazoff, PhD

>

> ***HBV Journal Review: September 2009

> by Kukka

>

> ***HEPATITIS JOURNAL REVIEW: August 25 , 2009 Volume 6, Issue 8

> by Liz HighleymanTo download pdf version click here

>

> In This Issue:

>

> Genetic Variation Predicts Response

> Statins Active Against HCV

> Steatosis

> Cardiovascular Risk

>

> HCV Transmission among HIV Positive Gay Men

>

>

>

> ***Reporting Drug Side Effects

> by Alan Franciscus

>

> *** HCV ADVOCATE WEEKLY NEWS REVIEW:

> A Review of HCV, HBV and HIV/HCV Coinfection Related News and Highlights

>

> Week Ending: August 29, 2009

>

> Alan Franciscus

> Editor-in-Chief

>

> To download pdf version click here

>

>

> This Issue:

>

> Novel Targets for specific therapy of hepatitis C

> U.S. probes Roche, Glaxo diet drug over liver injury

> Salix Pharmaceuticals Announces FDA Acceptance for Filing and Priority

> Review Designation for Rifaximin NDA for the Maintenance of Remission of

> Hepatic Encephalopathy

> Court to rule on whether hepatitis cases can proceed

> Fat In the Liver -- Not the Belly -- Is a Better Marker for Disease Risk

> Bradley Corp Releases Results of National Hand Washing Survey

> Is endotoxin receptor CD14 rs2569190/C-159T gene correlated with chronic

> hepatitis C?

> VA Negligence Suits Likely after Botched Colonoscopies

> In HIV-HCV Coinfection, HCV Clearance Reduces Overall Mortality

> China donor drive aims to end prisoner organ trade

> Lower Tacrolimus Dose Is Suitable For Living Donor Liver Transplantation

> With Small-For-Size Graft

> A Potential Therapeutic Agent For Hepatic Fibrosis

> The Flomax incident

> Study of Racial Disparity in Patients Undergoing Liver Transplantation for

> Hepatitis B

> Shortage of Donor Livers - An Every Day Dilemma for UK Doctors

>

>

> *** Be sure to check out the latest event notices at both the HCV and HBV

> Advocate websites

>

> HCV Events

> HBV Events

>

>

> Thanks!

>

> Alan Franciscus

> Executive Director, Hepatitis C Support Project

> Editor-in-Chief, HCV Advocate

>

>

>

> **Questions and Comments: If you have questions or comments please do not

> reply to this email. Questions and/or comments can be directed to

> alanfranciscus@...

>

> **Unsubscribe Information:

[Guest guest]

>

> To:

> Subject: HCV Advocate Email Alert

> Date: Wed, 23 Sep 2009 16:06:26 -0400

>

>

>

> Hello,

>

> The following items have been posted to www.hcvadvocate.org and

> www.hbvadvocate.org.

>

>

>

> *** Hepatitis E (HEV) New!

>

>

>

> *** Short Term Disability Benefits New!

> by Jacques Chambers, CLU, Benefits Consultant

>

>

> *** Top 10 HCV Downloads of the Month (English & Spanish) New!

>

> *** Top 10 HBV Downloads of the Month New!

>

> *** HCV ADVOCATE WEEKLY NEWS REVIEW:

> A Review of HCV, HBV and HIV/HCV Coinfection Related News and Highlights

>

> Week Ending: September 19, 2009

>

> Alan Franciscus

> Editor-in-Chief

>

> To download pdf version click here

>

>

> This Issue:

>

> Aspirin Could Diminish Hepatitis C Virus Replication

> California bill would toughen training for tattoo artists

> UPDATE 4-Dynavax shares soar as hepatitis B trials resume

> Interferon Gene Variant Predicts Response to Hepatitis C Treatment

> Celsion and the American Liver Foundation Partner to Promote Awareness of

> Primary Liver Cancer and the ThermoDox Phase III Global HEAT Study to

> Patients and Physicians

> Editorial: Medical Inattention in New York Prisons

> Physicians Are Talking About: The Million Med March on Washington

> Engineering Team To Design And Study Liver Mimics

> Aerobic Exercise Reduces Fatty Liver

> ChemDiv And IDialog Nominate Novel Inhibitor Of Hepatitis C For Clinical

> Development

> Uninsured Americans hope reform brings health coverage

> Hepatitis myths put Canadians at risk, survey warns

> Genetic Hint for Ridding the Body of Hepatitis C

> Are HBV Genotype B/B3 and C/C1 the Major Genotypes in Indonesia?

> New Micro-Bland Embolization Technique with Embozene Microspheres to Be

> Presented at the International Medical Conference in Lisbon, Portugal

> Pa. approves over-the-counter syringe sales

> Sticking it to the myths about hepatitis C

> Researchers Isolates Liver Cancer Stem Cells Prior to Tumor Formation

> Study links 45,000 U.S. deaths to lack of insurance

> Give your kidneys a break: lose some weight

> Cases of Liver Cancer Reduced in a Younger Population Vaccinated for HBV

> Prime Minister Bayar Diagnosed to Have Hepatitis C

> ICAAC: Hepatitis E Virus Finally Gets Some Respect

> University Hospital Coventry unveils life-saving liver scanner

>

> *** Be sure to check out the latest event notices at both the HCV and HBV

> Advocate websites

>

> HCV Events

> HBV Events

>

>

> Thanks!

>

> Alan Franciscus

> Executive Director, Hepatitis C Support Project

> Editor-in-Chief, HCV Advocate

>

>

>

> **Questions and Comments: If you have questions or comments please do not

> reply to this email. Questions and/or comments can be directed to

> alanfranciscus@...

>

> **Unsubscribe Information:

[Guest guest]

Good article on Swine Flu H1N1. I'll be getting both shots when they are

available. Besides having cirrhosis, I don't have a spleen so my bouts with

colds and the flu are worse than normal.

>

> To:

> Subject: HCV Advocate Email Alert

> Date: Wed, 30 Sep 2009 20:02:22 -0400

>

>

>

> Hello,

>

> The following items have been posted to www.hcvadvocate.org and

www.hbvadvocate.org.

>

>

>

> *** HCV Advocate Newsletter: October 2009

> Download printable version

>

> In This Issue:

>

> Unlocking Interferon

> Alan Franciscus, Editor-in-Chief

>

> Top 10 Post Counseling Messages

> Alan Franciscus, Editor-in-Chief

> , Hepatitis C Coordinator

> Hawai`i Department of Health

>

> HealthWise: Swine Flu

> Lucinda Porter, RN

>

> Treating Hepatitis C in Prison

> Liz Highleyman

>

> Symptoms and Complications of Cirrhosis

> Alan Franciscus, Editor-in-Chief

>

>

>

> *** HBV Journal Review: October 2009

> by Kukka

>

>

> *** HCV ADVOCATE WEEKLY NEWS REVIEW:

> A Review of HCV, HBV and HIV/HCV Coinfection Related News and Highlights

>

> Week Ending: September 26, 2009

>

> Alan Franciscus

> Editor-in-Chief

>

> To download pdf version click here

>

>

> In This Issue:

>

> Depressing trends in liver transplants look set to continue

> Health care Rx for N.Y. prisons

> Hollis: Test can bring 'silent killer' into the light

> New Guidelines Help Primary Care Doctors Treat Liver Transplant Recipients

> Liver failure brings dilemma in possible death penalty case

> Hepatoma: Deadly

> Data Safety Monitoring Board Recommends Continuation of Celsion's Phase III

ThermoDox® Study for Primary Liver Cancer

> Risky Behaviors among Truckers Lead to Higher Rates of STIs Including

Hepatitis C

> Mediterranean diet trims the wallet

> Hepatitis B Vaccine Fails in Half of all Celiac Patients: Is it Time to

Re-evaluate Current Immunization Strategies?

> Prisons can't contain rising medical costs

> Lawyers: More cases of hepatitis discovered

> Discovery could improve hepatitis C treatment

> Hope for Hepatitis C patients: two new drugs on horizon

> Shasta County supervisors extend needle exchange program

> Unanimous support for free crack pipes plan

> Everyone Should Be Tested for 'Hidden Disease' of Hepatitis C

> The 60th Annual Meeting of the American Association for the Study of Liver

Diseases

> HCV: Wait for Something New or Treat Now?

> Rockefeller virologists and MIT tissue engineers receive $5.8 million NIH

grant to study hepatitis

> Woman wins 'lonely battle' with infectious disease

> Override Lynch's med marijuana veto

> Vertex Pharmaceuticals Announces Publication of Telaprevir Abstracts for

Presentation at the 60th AASLD Meeting

> UW performs rare 2-for-1 'domino' transplant

> Worker in Hepatitis Case Is Sentenced to 20 Years

>

>

> *** Be sure to check out the latest event notices at both the HCV and HBV

Advocate websites

>

> HCV Events

> HBV Events

>

>

> Thanks!

>

> Alan Franciscus

> Executive Director, Hepatitis C Support Project

> Editor-in-Chief, HCV Advocate

>

>

>

> **Questions and Comments: If you have questions or comments please do not

reply to this email. Questions and/or comments can be directed to

alanfranciscus@...

>

> **Unsubscribe Information:

[Guest guest]

>

> To:

> Subject: HCV Advocate Email Alert

> Date: Wed, 21 Oct 2009 13:53:02 -0400

>

>

>

> Hello,

>

> The following items have been posted to www.hcvadvocate.org and

www.hbvadvocate.org.

>

>

>

> *** Action Alert

> Help ensure that the NHAS fully addresses people living with and at-risk for

both HIV and viral hepatitis by voicing your concerns at the community

discussion.

>

>

>

> *** World Hepatitis Alliance 2010 Communications Plan

> Where Are We Now? The Five Year Plan, Two Years In.

>

>

>

> *** Speeding Up Your Social Security Claim, by Jacques Chamber, CLU

> Getting Social Security to make a decision on a claim for disability has never

been a rapid process, however, it is now taking even longer. Claims for

disability have increased dramatically, but the staff at Social Security has

not.

>

>

>

> *** Take the HBV Quiz

> Be sure to check out our latest interactive learning tool

>

>

> *** Top 10 HCV Downloads of the Month (English & Spanish)

>

> *** Top 10 HBV Downloads of the Month

>

> *** HCV ADVOCATE WEEKLY NEWS REVIEW:

> A Review of HCV, HBV and HIV/HCV Coinfection Related News and Highlights

>

> Week Ending: Octber 17, 2009

>

> Alan Franciscus

> Editor-in-Chief

>

> To download pdf version click here

>

>

> This Issue:

>

> AIDS, Hepatitis C Cases Increasing in Montana

> B Here Raises Awareness for UCI

> Alert Over Donor Organs Riddled with Cancer, Mad Cow Disease and Hepatitis

> Haemophiliacs with HIV to Sue Firm that Sold Tainted Drug in Asia

> China to Stop Mandatory Hepatitis B Tests: State Media

> DPP Refuses to Reveal Reason for Dropping Hep C Charges

> When Good Medical Care is All or Something

> Endoscopy Plaintiffs Target Drug Suppliers

> UCSD Researchers Pave the Way for Effective Liver Treatments

> Report Calls for Global U.N. Pact to Ban Organ Sales

> Liver Stiffness Scan Shows Cirrhosis

> Hospital in Milan, Illinois to Help Pay for Hepatitis-A Shots

> Keep Body's 'Chemical Plant' in Good Working Order

> Cyplasin Biomedical Ltd., Announces Hepatitis C Product Licensing Deal

> Schering-Plough Highlights Boceprevir, Narlaprevir (SCH 900518) and

PEGINTRON® Data at the American Association for the Study of Liver Diseases

(AASLD) 2009 Annual Meeting

> Aethlon Medical to Present Data on HVC Patients Treated with its Hemopurifier

at the 42nd ASN Meeting

> Women with HIV Co-Infected with Hepatitis B or C Have Increased Risk of Bone

Problems

> Former Drug Addict Urges More to Take Hepatitis Test

> Subaru Donates 'Hep B Hero Mobile' to Support Campaign

> Florida Hospital Confirms Patients Infected by Reused IV Bags

> Website Warns Asian Community of Hepatitis C Dangers

> CAMP Rehoboth to Offer Free Hepatitis Vaccinations

> Race for a Cause: Hepatitis C

>

> *** Be sure to check out the latest event notices at both the HCV and HBV

Advocate websites

>

> HCV Events

> HBV Events

>

>

> Thanks!

>

> Alan Franciscus

> Executive Director, Hepatitis C Support Project

> Editor-in-Chief, HCV Advocate

>

>

>

> **Questions and Comments: If you have questions or comments please do not

reply to this email. Questions and/or comments can be directed to

alanfranciscus@...

>

> **Unsubscribe Information:

[Guest guest]

>

> To:

> Subject: HCV Advocate Email Alert

> Date: Wed, 18 Nov 2009 16:43:58 -0500

>

>

>

> Hello,

>

> The following items have been posted to www.hcvadvocate.org and

> www.hbvadvocate.org.

>

>

>

> *** AASLD 2009 HCV Coverage

> Check this link daily for onsite updates on posters and presentations from

> this year's conference.

>

>

>

> *** Special Presentation: Combination Therapy With A Nucleoside Polymerase

> (RG7128) And Protease (RG7227/ITMN ITMN-191) Inhibitor In HCV: Safety,

> Pharmacokinetics, And Virologic Results From INFORM INFORM-1

>

>

>

> *** Healthcare Reform, by Jacques Chambers, CLU

> Be sure to check out this insightful review of main issues under discussion

>

>

>

>

> *** Top 10 Downloads of the Month

>

> HCV

> HBV

>

>

>

> *** HCV ADVOCATE WEEKLY NEWS REVIEW:

> A Review of HCV, HBV and HIV/HCV Coinfection Related News and Highlights

>

> Week Ending: November 14, 2009

>

> Alan Franciscus

> Editor-in-Chief

>

> To download pdf version click here

>

>

> This Issue:

>

> AASLD: HCV-Related News

> AASLD: HBV-Related News

> Giving Back: Greenview

> Brookline, Lexington Students Advance in National Contest

> Prison Hep C Problem Will Cost Millions, MPs Told

> Bill Would Limit Needle Exchanges

> Doc Offers Top Hep C Drug Picks: BioBuzz

> A Life-Changing Liver Transplant

> Patients with More Difficult to Treat Forms of Hepatitis C Are Half as

> Likely to Treat the Disease

> Costrini: Advances in Hepatitis C Care Improve Odds of Cure

> Aduro Biotech Completes Series A-1 Financing

> A New Solution to Liver Disease Detection

> NVHR: New JAMA Article Underscores Urgent Need for Congress to Act on

> Viral Hepatitis Detection, Management Funding

> Largest-Ever Database for Liver Proteins May Lead to Treatments for

> Hepatitis

> Stigma and Hepatitis C

> Sexual Transmission Blamed for High HBV Infection Rate

> Boy and Sadie Frost Back Hepatitis C Campaign

> Bankruptcy Trustee: Leave the Hepatitis Claims to Us

> Tamara Browning: Donor Sabbath Scheduled Sunday

> Roseburg's Harm Reduction Center Holding Fundraiser

> Government Hepatitis Liability Ends with $44 K Payout to Veteran

>

>

> *** Be sure to check out the latest event notices at both the HCV and HBV

> Advocate websites

>

> HCV Events

> HBV Events

>

>

> Thanks!

>

> Alan Franciscus

> Executive Director, Hepatitis C Support Project

> Editor-in-Chief, HCV Advocate

>

>

>

> **Questions and Comments: If you have questions or comments please do not

> reply to this email. Questions and/or comments can be directed to

> alanfranciscus@...

>

> **Unsubscribe Information:

[Guest guest]

>

> To:

> Subject: HCV Advocate Email Alert

> Date: Tue, 1 Dec 2009 15:51:09 -0500

>

>

>

> HCV ADVOCATE EBLAST

> December 1, 2009

>

>

> Hello,

>

> The following items have been posted to www.hcvadvocate.org and

www.hbvadvocate.org .

>

>

>

> ***HCV Advocate Newsletter: December 2009

> Download printable version

> In This Issue:

>

> AASLD 2009 - Part 1

> Alan Franciscus, Editor-in-Chief

>

> HealthWise: Hepatitis C Update

> Lucinda Porter, RN

>

> How Do Targeted Anti-HCV Drugs Work?

> Liz Highleyman

>

> Jamalot

> C.D. Mazoff, PhD, Managing Editor/Webmaster

>

> HCV among Truck Drivers

> Alan Franciscus, Editor-in-Chief

>

>

>

> ***Hepatitis Journal Review : November 2009

> by Liz Highleyman

> To download pdf version click here

>

> In This Issue:

>

> Acute vs. Chronic HCV Diagnosis

> Spontaneous HCV Clearance in Children

> Treatment Response in Older Patients

> Retreatment of Nonresponders

>

> Response and Relapse in HIV/HCV Coinfected Patients

> Coinfection with Advanced Immune Suppression

>

>

>

> ***HBV Journal Review : December 2009

> by Kukka

>

>

>

> *** Medicare Annual Enrollment

> Between November 15 and December 31, if you are on Medicare you can:

>

> Change from Original Medicare to a Medicare Advantage Plan.

> Change from a Medicare Advantage Plan back to Original Medicare.

> Switch from one Medicare Advantage Plan to another Medicare Advantage Plan.

>

> Read more......................

>

>

>

> *** HCV ADVOCATE WEEKLY NEWS REVIEW:

> A Review of HCV, HBV and HIV/HCV Coinfection Related News and Highlights

> Week Ending: November 28, 2009

>

> Alan Franciscus

> Editor-in-Chief

>

> To download pdf version click here

>

>

> This Issue:

>

> Backed by House, 6 patients sue Pawlenty, state officials

> Increasing Long-Term Survival in Patients with Severe Liver Cancer

> Diet Rich in Processed Food Linked to Increased Risk for Depression

> My View: Ignoring Prisoners' Health Imperils Community

> Pharmasset Announces the Continued Enrollment of the Phase 2b Clinical Trial

of RG7128 for the Treatment of Hepatitis C

> Antiviral Therapy for Hepatitis C Appears To Be Declining in the U.S.; Lack of

Diagnosis Is Primary Barrier to Treatment

> Advanced Hepatitis Drug Nears FDA Approval

> NVHR: New Data Finding Fewer than 1 in 5 Hepatitis C Patients Receiving

Antiviral Therapy is 'Wake-Up Call' for Washington to Act

> Women's Health: Combating a Common Virus

> Vitamin D Boosts Treatment of Chronic Hepatitis C

> Human Genome Sciences Submits BLA to FDA for ZALBIN for Chronic Hepatitis C

> Scientists See Little Difference in Survival Rates between Non-Alcoholic and

Alcoholic Liver Transplants

> Tips for Managing the Flu with Liver Disease

> Metobolomics Uncovers Key Indicators of Nonalcoholic Fatty Liver Disease

> New Data Emerges on Liver Transplant Survival Rates

> Needle Sticks Can Be a Job Hazard for Medical Students

> Future of Maine's Needle Exchange Programs in Doubt

> Vibrating Technology Promises to Replace Biopsies in Diagnosing Diseased

Tissue

> Tripep: The ChronVac-C® Study Has Been Successfully Completed with Good

Safety and Favorable Clinical Data

> With Jesper Mattsson

>

>

> *** Be sure to check out the latest event notices at both the HCV and HBV

Advocate websites

>

> HCV Events

> HBV Events

>

>

> Thanks!

>

> Alan Franciscus

> Executive Director, Hepatitis C Support Project

> Editor-in-Chief, HCV Advocate

>

>

>

> **Questions and Comments: If you have questions or comments please do not

reply to this email. Questions and/or comments can be directed to

alanfranciscus@...

>

> **Unsubscribe Information:

[Guest guest]

>

> To:

> Subject: HCV Advocate Email Alert

> Date: Thu, 10 Dec 2009 15:48:27 -0500

>

>

>

> HCV ADVOCATE EBLAST

> December 10, 2009

>

>

> Hello,

>

> The following items have been posted to www.hcvadvocate.org and

> www.hbvadvocate.org.

>

>

>

> DRUGS

> IN DEVELOPMENT

>

> Be sure to check out the latest developments in the HCV Drug Pipeline:

> Click here.

>

>

>

> FACTSHEETS

>

> Disease Progression: Symptoms and Complications of Cirrhosis

> HCV Education & Support: Top 10 Counseling Messages

> Bulgarian Translation of HCSP HCV Factsheets

> Bulgarian Translation of HCSP HBV Factsheets

>

>

>

> WEEKLY NEWS REVIEW

>

> *** HCV ADVOCATE WEEKLY NEWS REVIEW:

> A Review of HCV, HBV and HIV/HCV Coinfection Related News and Highlights

> Week Ending: December 5, 2009

>

> Alan Franciscus

> Editor-in-Chief

>

> To download pdf version click here

>

>

> This Issue:

>

> What Happens When Doctors Give Patients More Power?

> The ABCs of Hepatitis

> Law to Offer Comprehensive Relief to Hepatitis Patients Enacted

> HCV Infection Tied to Increased Mortality in HIV+ Patients During HAART Era

>

> New Guidelines on Reporting Industry-Supported Clinical Trial Results

> Former Army Nurse Gets Prison in Hepatitis C Case

> Fine Levied against Illegal Tattooist

> Metabolic Syndrome Prevalent after Liver Transplant

> New Hepatitis C Treatment Shows Promise

> Reused Syringe Victims Eye Insurers in Vegas

> Diclofenac Linked to Liver Failure, Death

>

>

>

> EVENTS

>

> *** Be sure to check out the latest event notices at both the HCV and HBV

> Advocate websites

>

> HCV Events

> HBV Events

>

>

> Thanks!

>

> Alan Franciscus

> Executive Director, Hepatitis C Support Project

> Editor-in-Chief, HCV Advocate

>

>

>

> **Questions and Comments: If you have questions or comments please do not

> reply to this email. Questions and/or comments can be directed to

> alanfranciscus@...

>

> **Unsubscribe Information:

[Guest guest]

>

> To:

> Subject: HCV Advocate Email Alert

> Date: Tue, 19 Jan 2010 22:05:06 -0500

>

>

>

> HCV ADVOCATE EBLAST

> January 19, 2010

>

>

> Hello,

>

> The following items have been posted to www.hcvadvocate.org and

www.hbvadvocate.org.

>

>

>

> E-Alert from WHA

>

> An important message from the World Hepatitis Alliance concerning World

Hepatitis Day 2010

>

>

>

> Top 10 Downloads

>

> Top 10 HepB Downloads of the Month (January 2010)

> Check out what everyone has been reading

>

> Top 10 HCV Downloads of the Month / Las 10 descargas más frecuentes del mes

-- Updated January 2010

> HCSP publishes a variety of Educational Materials which you can download and

use in your community. Each month we will post the top 10 downloads of the

month, for both English and Spanish.

>

>

>

> WEEKLY NEWS REVIEW

>

> *** HCV ADVOCATE WEEKLY NEWS REVIEW:

> A Review of HCV, HBV and HIV/HCV Coinfection Related News and Highlights

> Week Ending: January 16, 2010

>

> Alan Franciscus

> Editor-in-Chief

>

> To download pdf version click here

>

>

> This Issue:

>

>

> Treatment of Hepatitis C within a Methadone Maintenance Program Yields Results

Comparable to Treatment via Other Models of Care

> The Hepatitis C Generation: Are Baby Boomers More Prone To Hepatitis C?

> Hepatitis C Group Launches to Aid Thousands of Edinburgh Victims

> After Years of Drugs, Stealing Dayton Native Turned Life Around, Became Nurse

> Achillion Announces Additional Positive Phase 1b Data with ACH-1625 to Treat

Hepatitis C

> Idenix Pharmaceuticals Highlights Progress in Three HCV Programs

> Vertex to Ask for Telaprevir OK Later in 2010

> My Turn: What Happens after Hepatitis

> Human Genome Sciences Reports Increasing Momentum toward Commercialization

> Reinfection after Liver Transplantation

> Virtual Liver Offers Better Chance of Life

> Coffee Cuts Liver Scarring in Hepatitis C

> Hepatitis B and C Often Ignored as Health Threat to Blacks

> IOM & Viral Hepatitis

> IOM Recommends National Strategy for Hepatitis B and C

> InterMune Updates Development Program of Protease Inhibitor RG7227 for

Treatment of Hepatitis C - Update

> Liver Lines

> Mayor Newsom Convenes Task Force to Address Hepatitis C Epidemic

> field Officer Kurt Beach Wants Workers' Compensation Law Changed

> Doctor: Drug War Waged against Wrong People

> A Novel and Simple Formula to Predict Treatment Success in Chronic Hepatitis C

> Hepatitis E: A Public Health Concern

> New HIV and Hepatitis C Treatment Centre Opens in Waterloo

> AASLD Applauds Landmark IOM Study That Shows the Path to Eradicate Hepatitis B

and C

> Government Appoints New Clinical Director for Liver Diseases

> Tylenol, Motrin, Benadryl, St. ph Aspirin, Rolaids Recall

> HCV Found in Carotid Atherosclerosis Plaques of Chronic Hepatitis C Patients

> Canadian Safe-Injection Site to Remain Open

> Adding Ketoprofen to Treatment for Chronic Hepatitis C: A Phase II Study

>

>

>

> EVENTS

>

> *** Be sure to check out the latest event notices at both the HCV and HBV

Advocate websites

>

> HCV Events

> HBV Events

>

>

> Thanks!

>

> Alan Franciscus

> Executive Director, Hepatitis C Support Project

> Editor-in-Chief, HCV Advocate

>

>

>

> **Questions and Comments: If you have questions or comments please do not

reply to this email. Questions and/or comments can be directed to

alanfranciscus@...

>

> **Unsubscribe Information:

[Guest guest]

>

> To:

> Subject: HCV Advocate Email Alert

> Date: Mon, 1 Feb 2010 15:16:45 -0500

>

>

>

> HCV ADVOCATE EBLAST

> February 1 , 2010

>

>

> Hello,

>

> The following items have been posted to www.hcvadvocate.org and

www.hbvadvocate.org.

>

>

>

> HCV ADVOCATE NEWSLETTER

>

> February 2010 HCV Advocate

>

> Download printable version

>

> In This Issue:

>

> IOM Report

> Alan Franciscus, Editor-in-Chief

> HealthWise: Milk Thistle

> Lucinda Porter, RN

> HCV Drug Resistance

> Liz Highleyman

> Disability & Benefits: Social Security and Blue Book Listings

> Jacques Chambers, CLU

>

>

>

> JOURNAL REVIEW

>

> HBV JOURNAL REVIEW:

>

> February 1 , 2010

> Volume 7, Issue 2

> M. Kukka

>

>

> DRUG PIPELINE

>

> Hepatitis C Treatments in Current Clinical Development - Updated February 1,

2010

>

>

> FACT SHEETS

>

> Hepatitis B

>

> Easy B's

>

> What is Cirrhosis?

> Diet

> Feeling Tired

> Gay Men, Sex & HBV

>

> Hepatitis B Basics

>

> Patient Assistance Programs

>

>

>

> WEEKLY NEWS REVIEW

>

> *** HCV ADVOCATE WEEKLY NEWS REVIEW:

> A Review of HCV, HBV and HIV/HCV Coinfection Related News and Highlights

> Week Ending: January 30, 2010

>

> Alan Franciscus

> Editor-in-Chief

>

> To download pdf version click here

>

>

> This Issue:

>

>

> Real-World Treatment Patterns, Non-Adherence, and Costs in Chronic Hepatitis C

> There Must Be a Place in the Guinness Book for Jette

> Paradigm Shift in Hepatitis C Testing May Curb the Numbers Affected, Says

Expert

> Unequal Outcomes despite Equal Treatment

> Engineering a New Way to Study Hepatitis C

> Dynavax Reports Positive Phase 1b Data for SD-101 in Chronic Hepatitis C

Infection

> 18 Hepatitis Cases to Be Settled

> Beyond the Ice: Technique for Preserving Pre-Transplant Livers Promises to

Improve Patient Outcomes and Expand the Organ Pool

> Proposed Study for Liver Cancer Previewed at Interventional Oncology Meeting

> Don't Fatten Your Liver

> Health Tragedy: Patients Denied Life-Saving Transplants for Their " Abuse of

Illicit Substances "

> NVHR Issues Challenge to Administration, Congress: Don't Leave 5 Million

Americans Afflicted with Chronic Viral Hepatitis out in the Cold with Budget

Freeze

> Tripep: Follow up of ChronVac-C®-Study with a 5th Dose Commenced

> Liver Transplants Do Not Impair Immune Response in HIV/HCV Coinfected Patients

> Race Team Promotes Hepatitis C Awareness

> Achillion Announces Nomination of ACH-2684 as Lead Clinical Candidate in

Resistance-Focused HCV Program

> Barlow Bill Grows out of Kurt Beach's Experience

> Coffee Break Boosts Memory

> Conatus Pharmaceuticals Initiates Phase II Clinical Trial in Combination with

Pegylated Interferon and Ribavirin for the Treatment of Hepatitis C Virus (HCV)

> Allegheny General Hospital Liver Transplant Program Certified

> Catholic Charities to Give Syringes to Drug Users

> Cancer in Remission, Now Comic Schimmel Needs a Liver Transplant

>

>

>

> EVENTS

>

> *** Be sure to check out the latest event notices at both the HCV and HBV

Advocate websites

>

> HCV Events

> HBV Events

>

>

> Thanks!

>

> Alan Franciscus

> Executive Director, Hepatitis C Support Project

> Editor-in-Chief, HCV Advocate

>

>

>

> **Questions and Comments: If you have questions or comments please do not

reply to this email. Questions and/or comments can be directed to

alanfranciscus@...

>

> **Unsubscribe Information:

[Guest guest]

>

> To:

> Subject: HCV Advocate Email Alert

> Date: Wed, 24 Feb 2010 15:20:35 -0500

>

>

>

> HCV ADVOCATE EBLAST

> February 24 , 2010

>

>

>

>

> Hello,

>

> The following items have been posted to www.hcvadvocate.org and

www.hbvadvocate.org.

>

>

>

> JOURNAL REVIEW

>

> Hepatitis Journal Review: Vol 7 no 2; February 2010

> by Liz Highleyman

> In This Issue:

>

> Shorter Treatment for HCV Genotype 1?

> HCV Found in Atherosclerosis Plaques

> Kidney Disease in HIV/HCV Coinfection

> Treatment of Injection Drug Users

> Partial Immunity to HCV?

>

>

>

> DRUG PIPELINE

>

> Hepatitis C Treatments in Current Clinical Development - Updated February 15,

2010

>

>

>

> FACT SHEETS

>

> Hepatitis B

>

> Easy B's

>

> Help with Medicines February 2010

> Medication Guide February 2010

> Taking HBV Medicines February 2010

> Herbs February 2010

> The Immune System February 2010

> Natural and Alternative Medicine February 2010

> Sleep February 2010

> Liver Cancer February 2010

>

>

>

> Hepatitis C

>

> Easy C's

>

> New Hep C Medicines February 2010

>

> Hepatitis C Basics

>

> Living with Hepatitis C: Managing Common Symptoms February 2010

>

> Hepatitis Fact Series

>

> Tips for Lowering Prescription Drug Costs February 2010

>

>

>

> Hepatitis C (Spanish)

>

> Datos Sencillos sobre la C

>

> ¿Qué es la Hepatitis C? (What is Hepatitis C?) Actualizado Febrero 2010

> Latinos (Latinos) Actualizado Febrero 2010

> Biopsia Hepática (Liver Biopsy) Actualizado Febrero 2010

> Dieta y Hepatitis C (Diet and Hepatitis C) Actualizado Febrero 2010

> Sueño y Hepatitis C (Sleep and Hepatitis C)Actualizado Febrero 2010

> Perforaciones Corporales y VHC (Piercing) Actualizado Febrero 2010

> Control de los Efectos Secundarios (Managing Side Effects) Actualizado Febrero

2010

>

>

>

> Top 10 Downloads

>

> Top 10 HepB Downloads of the Month (February 2010)

> Check out what everyone has been reading

>

> Top 10 HCV Downloads of the Month / Las 10 descargas más frecuentes del mes

-- February 2010

> HCSP publishes a variety of Educational Materials which you can download and

use in your community. Each month we will post the top 10 downloads of the

month, for both English and Spanish.

>

>

>

> WEEKLY NEWS REVIEW

>

> *** HCV ADVOCATE WEEKLY NEWS REVIEW:

> A Review of HCV, HBV and HIV/HCV Coinfection Related News and Highlights

> Week Ending: February 20, 2010

>

> Alan Franciscus

> Editor-in-Chief

>

> To download pdf version click here

>

>

> This Issue:

>

> Certain Syringes More Likely to Spread Hepatitis C Virus among Drug Users

> Scioto County Ranks First in Hepatitis C Cases

> Transfusion Victim Fights for Pay-Out

> Survey of HBsAg-Positive Pregnant Women and Their Infants Regarding Measures

to Prevent Maternal-Infantile Transmission

> Erythropoiesis-Stimulating Agents (ESAs): Procrit, Epogen and Aranesp: Drug

Safety Communication

> SHEA Releases Guidelines on Management of Healthcare Workers Infected with

Hepatitis, HIV

> Group Advocates Hepatitis C Education

> Bill Would Ease Ban on Selling Syringes

> Congress Considers Banning Medical Experiments on Chimpanzees

> Pharmasset Announces Complete Enrollment of RG7128 Phase 2b Clinical Study

> Dynavax Receives Canadian Approval to Conduct Phase 3 Trials of HEPLISAVT

> FDA Warns of Maalox Mix-up Danger

> Transplants Can Give Cirrhosis Patients a Brand-New Start, but Supply of Liver

Donors Is Short

> Guitar Legend Reveals Virus Shock

> The Lack of Needles and the Damage Done

> Clinic's Patients Warned of Hepatitis C Outbreak

> Drug Diversion Needs More Compliance Attention; Hospital Technician Is Heading

to Prison

> 'Right to Know' Bill Would Impact Inmates with Diseases

>

>

>

> EVENTS

>

> *** Be sure to check out the latest event notices at both the HCV and HBV

Advocate websites

>

> HCV Events

> HBV Events

>

>

> Thanks!

>

> Alan Franciscus

> Executive Director, Hepatitis C Support Project

> Editor-in-Chief, HCV Advocate

>

>

>

> **Questions and Comments: If you have questions or comments please do not

reply to this email. Questions and/or comments can be directed to

alanfranciscus@...

>

> **Unsubscribe Information:

[Guest guest]

>

> To:

> Subject: HCV Advocate Email Alert

> Date: Wed, 31 Mar 2010 01:20:36 -0400

>

>

>

> March 31, 2010

>

>

>

> HCV »

> HCV Advocate Newsletter, April 2010

> »

> Hepatitis Journal Review March 2010

> »

> News Review: March 27

> »

> Action Alert H.R.3974

> »

> New Videos

>

>

>

> Greetings from the HCV and HBV Advocate Websites:

> We have recently posted many new articles, journals and the April 2010 HCV

Advocate newsletter. Please click on the titles listed in the side bars to take

you directly to the newly posted items on the HBV and HCV Advocate Websites.

> As you know May is Hepatitis Awareness Month and May 19th is World Hepatitis

Day. There will be many rallies and events during the month of May about viral

hepatitis. Probably the most important one is going to be held in Washington

D.C.:

> Raise your voice: Are you angry that the government hasn't taken viral

hepatitis seriously enough to fund it at an appropriate level? Do you want to

give a voice to the viral hepatitis movement? If so, join us in Washington D.C.

for a rally on May 19, 2010 to demand that Congress take notice and action of

viral hepatitis. It's time that we raise our voices and be heard. For more

information about the rally visit www.nvhr.org

> .

> Sincerely,

>

> Alan Franciscus

> Executive Director, Hepatitis C Support Project

> Editor-in-Chief, HCV Advocate www.hcvadvocate.org

> Editor-in-Chief, HBV Advocate www.hbvadvocate.org

>

> **Questions and Comments: Questions and/or comments can be directed to

alanfranciscus@...

> **To receive the eblast in your email inbox simply send an e-mail to:

listserv@... with nothing in the subject line and the following

in the message body: subscribe emailalert. Make sure your email address is all

lower case.

>

>

> HBV »

> HBV Journal Review: April 2010

> »

> HBV Poster: Staying Healthy with Hepatitis B Updated

> »

> New: HBV Training Page

>

>

>

[Guest guest]

>

> To:

> Subject: HCV Advocate Email Alert

> Date: Wed, 7 Apr 2010 20:43:04 -0400

>

>

>

> April 7, 2010

>

>

>

>

> HCV »

> News Review: April 3, 2010 »

> Updated: HCV Basics Factsheets »

> Updated HCSP Russian Factsheets - ???????? ????????? ? ????? 2010 »

> HCV Training Workshop Schedule »

> Action Alert: Increased Funding

>

>

>

> Greetings from the HCV and HBV Advocate Websites:

> Be sure to check out our updated popular HCV Basics Factsheets. This week we

have updated the General Information and HCV Disease Progression sections.

> As well, we have recently updated some Russian translations of our HCSP

Factsheet Series.

> ??????????? ?????????? ??? ??????? ??????????? ????????? ???????????

??????????

> Also: remember to check the training pages on both the HCV and HBV Advocate

websites to see what's coming to your area and to register early!!!

> Finally: TAKE ACTION: Call Your Two Senators THIS MONTH to Support Increased

Viral Hepatitis Prevention Funding. The deadline is April 16, so do it now.

> .

> Sincerely,

> Alan Franciscus

> Executive Director, Hepatitis C Support Project

> Editor-in-Chief, HCV Advocate www.hcvadvocate.org

> Editor-in-Chief, HBV Advocate www.hbvadvocate.org

>

> **Questions and Comments: Questions and/or comments can be directed to

alanfranciscus@...

> **To receive the eblast in your email inbox simply send an e-mail to:

listserv@... with nothing in the subject line and the following

in the message body: subscribe emailalert. Make sure your email address is all

lower case.

>

>

> HBV »

> HBV Training Workshop Schedule »

>

> HBV Poster: Staying Healthy with Hepatitis B Updated »

> HBV Journal Review: April 2010

>

>

>

[Guest guest]

>

> To:

> Subject: HCV Advocate Email Alert

> Date: Sun, 2 May 2010 21:38:23 -0400

>

>

>

> May 2 , 2010

>

>

>

> HCV »

> HCV Advocate Newsletter: May 2010 »

> Hepatitis Journal Review: April , 2010 »

> Weekly News Review: May 1, 2010 »

> HCV Drugs in Development: May 2, 2010 »

> HCV Training Workshop Schedule

>

>

>

> Hello,

> Spring is finally here and it's the perfect time to get outside, exercise, and

make your voice heard. World Hepatitis Day is on May 19, 2010 and I hope you

will join the hundreds of hepatitis advocates who will be in Washington D.C. to

demand that the government finally fund hepatitis B and C. We need your voice!

Click here for more info

> On another advocacy note, we recently launched our national hepatitis B

training workshops with seminars scheduled for Sacramento, CA on May 3,

Philadelphia, PA on May 26, and Honolulu, Hawaii on June 30, 2010. A complete

list of HCSP's HCV and HBV trainings are listed on our Websites.

> We have many new items that have been posted to our HBV and HCV Websites

including the May HCV Advocate newsletter, the weekly news review, the HCV and

HBV Journal Review(s) as well as our updated HCV Drug Pipeline.

> Hope to see you in D.C.,

> Alan

> Join me on Twitter -

> Alan Franciscus

> Executive Director, Hepatitis C Support Project

> Editor-in-Chief, HCV Advocate www.hcvadvocate.org

> Editor-in-Chief, HBV Advocate www.hbvadvocate.org

>

> **Questions and Comments: If you have questions or comments please do not

reply to this email. Questions and/or comments can be directed to

alanfranciscus@...

> **Unsubscribe Information:

[Guest guest]

>

> To:

> Subject: HCV Advocate Email Alert

> Date: Tue, 25 May 2010 19:01:52 -0400

>

>

>

> May 25, 2010

>

>

>

> HCV »

> Weekly News Review: May 22, 2010 »

> Top 10 HCV Downloads of the Month (May 24) »

> Hepatitis Journal Review

>

>

>

> Hello:

> Exciting news was released today about the phase III studies of telaprevir

combination therapy.

> The top-line results released list a 75% SVR in the group that received 12

weeks of telaprevir/ Pegasys/ribavirin (triple combo) followed by 12 weeks of

Pegasys/ribavirin (without telaprevir) vs. a 44% SVR in the group that was

treated for 48 weeks with Pegasys/ribavirin (without telaprevir).

> In another arm of the trial, people who received just 8 weeks of triple

therapy followed by Pegasys/ribavirin achieved an SVR of 69%.

> See Vertex's press release for more information.

> We have also posted the Hepatitis Journal Review, our Weekly News Review, the

Top 10 Downloads of the Month for the HBV Advocate and HCV Advocate Web sites

and updated our Guide to Hepatitis B.

>

> Cheers,

> Alan

> Join me on Twitter -

> Alan Franciscus

> Executive Director, Hepatitis C Support Project

> Editor-in-Chief, HCV Advocate www.hcvadvocate.org

> Editor-in-Chief, HBV Advocate www.hbvadvocate.org

>

> **Questions and Comments: If you have questions or comments please do not

reply to this email. Questions and/or comments can be directed to

alanfranciscus@...

> **Unsubscribe Information:

[Guest guest]

>

> To:

> Subject: HCV Advocate Email Alert

> Date: Fri, 11 Jun 2010 17:54:29 -0400

>

>

>

> June 11, 2010

>

>

>

> HCV »

> Weekly News Review: June 5, 2010 »

> HCV Drug Pipeline Updated June 3, 2010 »

> Weekly News Review: June 5, 2010

>

>

>

>

> Hello:

> This week we have updated many of our Mental Health and Wellness series

hepatitis C fact sheets, as well as our Drug Pipeline.

> We have also updated one of our most in demand brohcures --The Liver - The

Basics, which can be ordered free of charge by clicking on any of these links

HCV Educational Materials, HBV Educational Materials.

> Finally, be sure to check out our Weekly News Review to catch up on the latest

news and information about HBV, HCV and HIV and hepatitis coinfections.

>

> Cheers,

> Alan

> Join me on Twitter -

> Alan Franciscus

> Executive Director, Hepatitis C Support Project

> Editor-in-Chief, HCV Advocate www.hcvadvocate.org

> Editor-in-Chief, HBV Advocate www.hbvadvocate.org

>

> **Questions and Comments: If you have questions or comments please do not

reply to this email. Questions and/or comments can be directed to

alanfranciscus@...

> **Unsubscribe Information:

[Guest guest]

>

> To:

> Subject: HCV Advocate Email Alert

> Date: Wed, 14 Jul 2010 14:46:38 -0400

>

>

>

> July 14, 2010

>

>

>

> HCV »

> HCV Drug Pipeline: Updated July 14, 2010 »

> Action Alert »

> HCSP Guides »

> Weekly News Review: July 10, 2010

>

>

>

>

> Hello,

> In this week's Eblast we have some very exciting new postings.

> First is the updated HCV Drug Pipeline that has information on TMC 436, a HCV

protease inhibitor (in combination with pegylated interferon plus ribavirin)

that showed fantastic interim results in a phase II study.

> It will be interesting to see if the final results of this study show the same

trend. Of course, the study is too small to give us all the information we need

but hopefully this positive data will help to push the triple combo forward into

phase III study.

> Another noteworthy item we posted was an Action Alert to get people to contact

their representative to support an increase of up to $50 million for viral

hepatitis prevention. Make yourself heard and hopefully we can get more funding

for viral hepartitis.

> We also have our News Review that was posted on Saturday as well as many HCSP

Guides have been reviewed and updated to reflect the newest information about

our understanding of various topics.

> Sincerely,

> Alan

>

> Join me on Twitter -

> Alan Franciscus

> Executive Director, Hepatitis C Support Project

> Editor-in-Chief, HCV Advocate www.hcvadvocate.org

> Editor-in-Chief, HBV Advocate www.hbvadvocate.org

>

> **Questions and Comments: If you have questions or comments please do not

reply to this email. Questions and/or comments can be directed to

alanfranciscus@...

> **Unsubscribe Information:

[Guest guest]

>

> To:

> Subject: HCV Advocate Email Alert

> Date: Mon, 2 Aug 2010 21:33:18 -0400

>

>

>

> August 2, 2010

>

>

>

> HCV »

> HCV Advocate Newsletter, August 2010 »

> HBV & HCV Advocate Hepatitis Blog »

> Hepatitis C and HIV/HCV Coinfection Powerpoint »

> Drug Pipeline: Updated July 30 »

> Weekly News Review: July 31, 2010

>

>

>

> Hello everyone,

> It's been another busy month at the HCV and HBV Advocate. The following items

have been recently posted:

> 1. HCV Advocate Newsletter, August 2010

> In This Issue:

>

> Read about the important new approval and discoveries regarding HCV diagnostic

tools:

> Advances in HCV Diagnostics: OraQuick® HCV Rapid Antibody Test; The

Bisosensor

> Alan Franciscus, Editor-in-Chief

> If you are lucky enough to have two health insurance policies this month's

Benefits Column is a must read:

> Disability & Benefits: Coverage Under Multiple Health Plans

> Jacques Chambers, CLU

> Best intentions are sometimes not always understood. " You look so good " can

often be interpreted poorly by someone with hepatitis C. Read Lucinda's take on

this:

> HealthWise: Words that Wound, Words that Heal

> Lucinda Porter, RN

> Research is yielding some amazing tools to predict treatment response. Read

about a variation in IL28B that 'predicts' treatment success in people with HCV

genotype 1:

> The Gene that Predicts

> Alan Franciscus, Editor-in-Chief

> 2. HBV and HCV Blog

> We just launched our HBV and HCV Blog. We plan to use this blog to answer

some of the questions that our website and training audiences ask. We already

have about 4 items-from various abstracts to general questions-that need to be

answered. We welcome comments from our audience-we just ask that you don't ask

personal health questions because we are not medical providers!

> Blog http://hcvadvocate.blogspot.com/

> 3. HBV Journal Review

> M. Kukka reviews important news and journal articles regarding HBV

treatment, disease progression, vaccination and more....

> HBV Journal Review: August 1, 2010, Vol 7, no 8

> 4. Weekly News Review - The best of the news on HCV, HBV and HIV and hepatitis

coinfections

> Week Ending July 31, 2010

> 5. Hepatitis C and HIV/HCV Coinfection - This is the entire slide presentation

that I used last week to present to the Montana HIV Community Planning Group.

> http://www.hcvadvocate.org/Training/HIV%20

> HCV%20Coinfection%202010.ppt

>

> Join me on Twitter -

>

>

>

> Alan Franciscus

> Executive Director, Hepatitis C Support Project

> Editor-in-Chief, HCV Advocate www.hcvadvocate.org

> Editor-in-Chief, HBV Advocate www.hbvadvocate.org

>

> **Questions and Comments: If you have questions or comments please do not

reply to this email. Questions and/or comments can be directed to

alanfranciscus@...

> **Unsubscribe Information:

[Guest guest]

If you have time watch Zirbes' presentation, a bit long but good info.

The Drug Pipeline update is worth a read for those who are 'Watchful Waiting'.

>

> To:

> Subject: HCV Advocate Email Alert

> Date: Sun, 22 Aug 2010 23:54:02 -0400

>

>

>

> August 22, 2010

>

>

>

> HCV »

> Zirbes on " Stigma " »

> Life Management During HCV Treatment »

> Your Doctor and Disability Support Letters »

> Top 10 HCV Downloads »

> Drug Pipeline: Updated August 16 »

> Weekly News Review: August 21, 2010

>

>

>

> Hello:

> This week's postings include the following topics:

> 1. From the Minnesota Viral Hepatitis Conference: Z of " 's Lot "

talks about her efforts to raise awareness of hepatitis C and about the Stigma

associated with hepatitis C. This is a very powerful video that I encourage you

to share with your family and friends to help educate them on some of the issues

we face in our everyday lives. Also, the slides from my presentation " Life

Management During HCV Treatment " have been uploaded to our Trainer's page.

> 2. The monthly Benefits Column by Jacques Chambers features an article about

working with your medical provider to make sure your medical records contain the

necessary information if you should ever need to file a disability claim or if

you are filing the claim now. The article is titled " Your Doctor and Disability

Support Letters. "

> 3. The " Top 10 Downloads " from the HCV and HBV Advocate Web sites - find out

what others are reading on our websites.

> 4. The Weekly News Review that has the top news stories on HCV, HBV and HIV

and hepatitis coinfections.

> 5. Rounding out the postings we updated the HCV Drug Pipeline which now

includes top-line results from the boceprevir and telaprevir phase III studies.

>

> To watch a video version of this eblast click here

>

> Join me on Twitter -

>

>

>

> Alan Franciscus

> Executive Director, Hepatitis C Support Project

> Editor-in-Chief, HCV Advocate www.hcvadvocate.org

> Editor-in-Chief, HBV Advocate www.hbvadvocate.org

>

> **Questions and Comments: If you have questions or comments please do not

reply to this email. Questions and/or comments can be directed to

alanfranciscus@...

> **Unsubscribe Information:

[Guest guest]

>

> To:

> Subject: HCV Advocate Email Alert

> Date: Thu, 30 Sep 2010 19:37:55 -0400

>

>

>

> September 30, 2010

>

>

>

>

> HCV »

> Updated Easy C Fact Sheets »

> Updated HCV Basics Fact Sheets »

> Updated FAQ's »

> HCSP Streaming Videos »

> Top 10 HCV Downloads »

> Hepatitis A: What You Need to Know

>

>

>

>

> Dear Readers,

> Thank you for taking the time out of your busy day to read this Eblast. I

wanted to make you aware of the new items we have uploaded to our HBV and HCV

Advocate Websites:

>

> October 2010 HCV Advocate Newsletter:

>

> REALIZE: Top-line results from the phase III trial of telaprevir, pegylated

interferon and ribavirin to treat people who did not achieve an SVR with a

previous course of pegylated interferon and ribavirin. You can also join me

on-line for an HCV Advocate Video Update on the trial results.

>

> Disability and Benefits: Life Settlements (Cash for Your Life Insurance

Policy) - read about the various types of life settlements, information about

the potential benefits and downsides to cash in on insurance.

>

>

> HealthWise: Finding Safety in Numbers by Lucinda Porter who discusses the

changing landscape of HCV disease progression and some thoughts about what it

means

>

>

> HCV Snapshots - short recaps of some interesting studies about hepatitis C

>

>

> SVR Reduces Risk of Death and Disease: Read about the very encouraging news

about the benefits of achieving an SVR and even the benefits of just going HCV

RNA undetectable while on HCV therapy.

>

> HBV Journal Review:

>

> Read about various issues and outcomes of HBV treatment, HBV transmission,

Immunizations strategies, articles and other important information about HBV.

>

> Be sure to check out the Herbal Dietary Supplements Glossary that we recently

reviewed and updated.

>

> Sincerely,

> Alan

>

>

> Join me on Twitter -

>

>

>

> Alan Franciscus

> Executive Director, Hepatitis C Support Project

> Editor-in-Chief, HCV Advocate www.hcvadvocate.org

> Editor-in-Chief, HBV Advocate www.hbvadvocate.org

>

> **Questions and Comments: If you have questions or comments please do not

reply to this email. Questions and/or comments can be directed to

alanfranciscus@...

> **Unsubscribe Information: